Commercialisation news

The latest commercialisation news from the University of º¬Ð߲ݴ«Ã½.

Off
Medical illustration of a brain with stroke symptoms

New company Midland Pharmaceuticals launched to develop therapeutics for stroke and spinal cord injury

Researchers from the University of º¬Ð߲ݴ«Ã½ and the University of Birmingham have joined forces with NLC Health Ventures to co-found a company developing new treatments for spinal cord injuries and stroke.
DNA Molecule

º¬Ð߲ݴ«Ã½ spinout company grows to lead on next generation biomedicines and bioprocesses

SynGenSys, a fast-growing biotechnology company spun out of the University of º¬Ð߲ݴ«Ã½, has announced the appointment of Dr. Andy Racher as its Commercial Operations Director.
A portrait photo of Professor James Marshall

World leading expert on bio-inspired AI to direct University of º¬Ð߲ݴ«Ã½â€™s Centre for Machine Intelligence

One of the world’s leading innovators in bio-inspired AI has joined the University of º¬Ð߲ݴ«Ã½, as part of a new multi-million pound centre that is set to transform the institution’s research, innovation and teaching around artificial intelligence.

Dr Tim Craggs with instrument

Northern Triangle Talent Project secures £1.5m funding to strengthen regional commercialisation activity

The Northern Triangle Talent Project has secured funding to strengthen the regional technology commercialisation ecosystem and attract top talent to the north of England.
DNA Molecule

University of º¬Ð߲ݴ«Ã½ spinout company to pioneer novel therapies for genetic neurological diseases

BlackfinBio has raised £2.75 million seed investment to advance revolutionary treatments for Hereditary Spastic Paraplegia (HSP).

º¬Ð߲ݴ«Ã½'s Diamond building seen in the º¬Ð߲ݴ«Ã½ skyline

º¬Ð߲ݴ«Ã½'s response to the independent review of university spin-out companies

º¬Ð߲ݴ«Ã½ welcomes the announcement of £20m to help universities develop more spinout companies made in the autumn statement, as well as the independent review of spin-out companies.
A close up of plastic pellets produced by Floreon

World’s first low-energy bioplastics developed with the University of º¬Ð߲ݴ«Ã½ raises £2 million investment

The world’s first low-energy, non-oil-based, high-performance bioplastic, developed by Floreon with the University of º¬Ð߲ݴ«Ã½, has secured £2 million financing from Northern Gritstone.

Neuron cells system - 3d rendered image of Neuron cell network on black background

University of º¬Ð߲ݴ«Ã½ spinout company Crucible Therapeutics raises £5 million to advance pioneering treatments for neurological diseases

University of º¬Ð߲ݴ«Ã½ spinout company, Crucible Therapeutics, a biotechnology company developing novel therapies to treat the most common genetic form of MND and frontotemporal dementia (FTD), has secured £5 million from Northern Gritstone.
An aerial view of the University of º¬Ð߲ݴ«Ã½ Innovation District featuring the Factory 2050 building

Investment zones are the key to taking our potential towards prosperity

Professor Koen Lamberts, President and Vice-Chancellor of the University of º¬Ð߲ݴ«Ã½, discusses how the new South Yorkshire Investment Zone can turn Yorkshire's potential into prosperity.

Inner ear

Unlocking the human inner ear for new therapies to improve hearing loss and deafness

An international team of scientists and surgeon has discovered a secure clinical pathway to the inner ear, which will enable the application of a range of regenerative therapies to restore hearing.

A blue sky above the University's Diamond building

Northern Gritstone secures first close of £215 million ahead of making its first investments

A new investment company founded by the universities of º¬Ð߲ݴ«Ã½, Leeds and Manchester to help boost the commercialisation of university spinouts and start-ups in the north of England has today (20 May 2022) announced a first close of £215 million.
Close up of ear

Rinri Therapeutics raises £10 million to advance stem cell therapy for hearing loss

University of º¬Ð߲ݴ«Ã½ spinout company, Rinri Therapeutics, has raised a total of £10 million from investors and the UK Future Fund to advance its novel stem cell therapy to restore hearing loss.

Abstract woman scientist illustration

º¬Ð߲ݴ«Ã½ spin-out set up to facilitate life-science discoveries

Understanding how molecules interact within the body is essential in supporting the development of treatments and therapies. Exciting Instruments, a University of º¬Ð߲ݴ«Ã½ spin-out company, is breaking down barriers for researchers in this field.
Thumbnail

Northern Gritstone announces leadership team

Northern Gritstone, a new investment company founded by the Universities of Leeds, Manchester and º¬Ð߲ݴ«Ã½, has appointed Lord Jim O’Neill as Non-Executive Chairman and Duncan Johnson as CEO.
Universities of º¬Ð߲ݴ«Ã½, Leeds and Manchester launch Northern Gritstone

Northern universities launch new investment company

The universities of º¬Ð߲ݴ«Ã½, Leeds and Manchester are launching a new investment company to help boost the commercialisation of university spinouts and start-ups in the North of England.